OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Nephrology and Hypertension is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Population Health Strategies for Health Equity in Chronic Kidney Disease Management: Retraction	31
Dual organ transplantation: Pancreas and Liver in the kidney axis	31
Medical nutrition therapy using plant-focused low-protein meal plans for management of chronic kidney disease in diabetes	29
The impact of conflicts on patients with chronic kidney disease	29
Effect of the allelic background on the phenotype of primary hyperoxaluria type I	24
The clinical application of frailty in nephrology and transplantation	22
The coronavirus disease 2019 pandemic: the disruptor that maintenance dialysis never anticipated	21
Tackling the intersectoral challenges in kidney diseases and transplantation: shared decision and realistic care for advanced diagnostic and therapeutic modalities for kidney diseases and transplantat	20
Barriers to home dialysis and kidney transplantation for socially disadvantaged individuals	19
Emerging strategies to reduce kidney function decline and improve cardiovascular outcomes	19
Editorial introductions	19
Interferon gamma in the pathogenesis of hypertension − recent insights	18
Does cooled dialysate still have a role in reducing intradialytic stress? Implications of the MyTEMP trial	17
Prediction models for earlier stages of chronic kidney disease	17
International equity in access to home dialysis	17
Editorial introduction	17
Maximizing opportunities for kidney transplantation in older adults	17
Renal denervation for the treatment of hypertension and kidney disease	16
Has the time come for age-adapted glomerular filtration rate criteria to define chronic kidney disease: how soon is now?	15
Reconciling Systolic Blood Pressure Intervention Trial with Eighth Joint National Commission: a nuanced view of optimal hypertension control in the chronic kidney disease population	15
Safety of SGLT2i with regard to bone and mineral metabolism in patients with CKD	15
Modern indications for referral for kidney and pancreas transplantation	15
Staying home when peritoneal dialysis ends: the integrated home dialysis approach	14
Recent advances in peritoneal dialysis catheter placement: the association between method of insertion, operator, and prior abdominal surgery and outcomes	14
Bringing the end-stage kidney disease life plan home	14

Calcium-binding protein 39 in with-no-lysine kinase signaling and the modulation of renal tubular transport	13
The race coefficient in glomerular filtration rate-estimating equations and its removal	13
Built environment and chronic kidney disease: current state and future directions	12
Synergistic susceptibility to environmental lead toxicity in chronic kidney disease	12
Plant-based diets for kidney disease prevention and treatment	12
Editorial: The evolution of my personal conflict of interest: I am part of an ‘ineligible company’	12
Dialysis initiation for patients with decompensated cirrhosis when liver transplant is unlikely	11
Which patients with CKD will benefit from genomic sequencing? Synthesizing progress to illuminate the future	10
Sodium phosphate cotransporter 2a inhibitors: potential therapeutic uses	10
Editorial: One size does not fit all: moving toward individualized therapy	10
Skeletal parathyroid hormone hyporesponsiveness: a neglected, but clinically relevant reality in chronic kidney disease	10
Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression	10
A basic solution for a complex problem: does treatment of metabolic acidosis slow CKD progression?	9
Combination therapy with kidney protective therapies: optimizing the benefits?	9
Kidney dysfunction requiring dialysis is a heterogeneous syndrome: we should treat it like one	9
Lipocalin-2: a novel link between the injured kidney and the bone	9
Complement detection in kidney biopsies – utility and challenges	9
Dietary protein intake and plant-dominant diets to mitigate risk of allograft dysfunction progression in kidney transplant recipients	9
Editorial introductions	9
Renal effects of cullin 3 mutations causing familial hyperkalemic hypertension	9
Understanding renal phosphate handling: unfinished business	9
Glucagon-like peptide-1 receptor agonists to improve cardiorenal outcomes: data from FLOW and beyond	8
A current update of the development of Chimeric Antigen Receptor T-cell therapy and kidney disease	8
Climate change and kidney stones	8
Cancer drugs and acute kidney injury: new therapies and new challenges	8
The current therapeutic approach for anaemia after kidney transplant	8
Mitochondrial bioenergetics: coupling of transport to tubular mitochondrial metabolism	8
Noninvasive continuous intradialytic blood pressure monitoring: the key to improving haemodynamic stability	8
When the earth shakes unexpectedly: impact on nephrology services and patients	8
Deep learning applications for kidney histology analysis	8
Recent updates in kidney risk prediction modeling: novel approaches and earlier outcomes	8
HIV-associated kidney disease: the changing spectrum and treatment priorities	8
Automation and innovation in home hemodialysis machines	8
Editorial: Advancements in the management of kidney disease and electrolyte derangements	8
Impact of intensive blood pressure control on kidney outcomes	8
Novel approaches to hypoglycemia and burnt-out diabetes in chronic kidney disease	8
Editorial introduction	7
Evolving thresholds for the diagnosis of acute T cell mediated rejection	7
Hypernatremia in the intensive care unit	7
Sex differences in renal electrolyte transport	7
Contemporary risk prediction models in chronic kidney disease: when less is more	7
Recent advances in dialysis membranes	7
Prospects for gene therapy in polycystic kidney disease	7
New therapeutic perspectives for vascular and valvular calcifications in chronic kidney disease	7
Editorial introductions	7
New insights into renal calcium-sensing receptor activation	7
Editorial: Innovations in multimodal and integrated approaches in kidney care and renal transplantation	7
Renal osteodystrophy: something old, something new, something needed	7
New and old approaches to nutritional management of acute and chronic glomerulonephritis	7
Epithelial Na+ channel and the glycocalyx: a sweet and salty relationship for arterial shear stress sensing	7

Vaccination in kidney disease: what did we learn from COVID-19 pandemic	6
Multimodal approaches for inequality in kidney care: turning social determinants of health into opportunities	6
Screening for chronic kidney disease: change of perspective and novel developments	6
Proximal tubule responses to injury: interrogation by single-cell transcriptomics	6
Kidney in the net of acute and long-haul coronavirus disease 2019: a potential role for lipid mediators in causing renal injury and fibrosis	6
Renal denervation: recent developments in clinical and preclinical research	6
Building kidney organoids from pluripotent stem cells	6
Novel intestinal dialysis interventions and microbiome modulation to control uremia	6
Evolving indications and management patterns in heart – kidney transplantation	6
Rare genetic disorders that impair parathyroid hormone synthesis, secretion, or bioactivity provide insights into the diagnostic utility of different parathyroid hormone assays	6
Exercise as a therapeutic intervention in chronic kidney disease: are we nearly there yet?	5
The genetics of cystinuria – an update and critical reevaluation	5
Targeting inflammation in hypertension	5
Fibroblast growth factor 23 as a risk factor for incident diabetes	5
The potential of artificial intelligence-based applications in kidney pathology	5
Editorial: Novel therapeutic approaches in chronic kidney disease and kidney transplantation: the draw of evolving integrated multimodal approaches in the targeted therapy era	5
Chronic kidney disease and sex dimorphism	5
Adverse effects during treatment with renin–angiotensin–aldosterone system inhibitors; should we stay or should we stop?	5
New guidelines and therapeutic updates for the management of lupus nephritis	5
The « race » correction in estimating glomerular filtration rate: an European point of view	5
Effects of aging on chronic kidney disease mineral and bone disorder	5
Cystatin C should be routinely available for estimating kidney function	5
Frailty, multimorbidity and sarcopaenia in haemodialysis patients	5
Novel approaches in antihypertensive pharmacotherapeutics	5
New therapeutics for primary hyperoxaluria type 1	5
Population health strategies for health equity in chronic kidney disease management	5
An update on corticosteroid treatment for IgA nephropathy	5
Novel agents for treating IgA nephropathy	5
The changing trajectory of diabetic kidney disease	5